Syndax Announces Participation in March Investor Conferences

robot
Abstract generation in progress

Syndax Pharmaceuticals will participate in three investor conferences in March 2026: the TD Cowen 46th Annual Health Care Conference, the Leerink Global Healthcare Conference, and the Barclays 28th Annual Global Healthcare Conference. CEO Michael A. Metzger and other management team members will host fireside chats at each event. Webcasts of these sessions will be available on the company website.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin